Armistice Capital, Llc Aytu Biopharma, Inc (AYTU) insider trading activity

Armistice Capital, LLC is Director of AYTU BIOPHARMA, INC. Currently has a direct ownership of 1.34 Million shares of AYTU, which is worth approximately $3.8 Million. The most recent transaction as insider was on Mar 29, 2021, when has been sold 2,085 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.34M

0% 3M change

0% 12M change

Total Value Held $3.8 Million

ARMISTICE CAPITAL, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 29 2021	BUY Other acquisition or disposition	-	2,085 Added 0.16%	1,342,378 Common Stock
Mar 20 2021	BUY Other acquisition or disposition	-	6,959 Added 0.52%	1,340,293 Common Stock
Dec 11 2020	BUY Open market or private purchase	$8,000,004 $6.0 p/Share	1,333,334 Added 50.0%	1,333,334 Common Stock
Apr 27 2020	SELL Open market or private sale	$9,298,236 $1.82 p/Share	5,108,921 Reduced 100.0%	0 Common Stock
Apr 27 2020	BUY Exercise of conversion of derivative security	$6,250,000 $1.25 p/Share	5,000,000 Added 49.46%	5,108,921 Common Stock
Apr 06 2020	BUY Other acquisition or disposition	-	108,920 Added 50.0%	108,921 Common Stock
Mar 10 2020	SELL Payment of exercise price or tax liability	$1,933,931 $1.3 p/Share	1,487,639 Reduced 7.59%	18,119,637 Common Stock

Mar 10 2020	SELL Open market or private sale	$27,092,966 $1.23 p/Share	22,026,801 Reduced 100.0%	1 Common Stock
Mar 10 2020	BUY Exercise of conversion of derivative security	$17,818,118 $1.17 p/Share	15,229,161 Added 40.88%	22,026,802 Common Stock
Feb 14 2020	BUY Other acquisition or disposition	-	335,279 Added 3.89%	8,285,279 Common Stock
Dec 20 2019	BUY Open market or private purchase	$22,880 $0.88 p/Share	26,000 Added 0.33%	7,950,000 Common Stock
Dec 19 2019	BUY Open market or private purchase	$44,870 $0.85 p/Share	52,788 Added 0.66%	7,924,000 Common Stock
Oct 30 2019	BUY Conversion of derivative security	$2,421,010 $0.88 p/Share	2,751,148 Added 25.9%	7,871,212 Common Stock
Apr 18 2019	BUY Other acquisition or disposition	-	3,120,064 Added 37.86%	5,120,064 Common Stock

Also insider at

AVTX

Avalo Therapeutics, Inc. Healthcare

> 10% Shareholder

BBI

Brickell Biotech, Inc. Healthcare

> 10% Shareholder

ALIM

ALIMERA SCIENCES INC Healthcare

> 10% Shareholder

KPRX

KIORA PHARMACEUTICALS INC Healthcare

> 10% Shareholder

SAVA

CASSAVA SCIENCES INC Healthcare

> 10% Shareholder

DFRG

Del Frisco's Restaurant Group, Inc.

> 10% Shareholder

VLRX

Valeritas Holdings Inc.

> 10% Shareholder

BPTH

BIO-PATH HOLDINGS INC Healthcare

> 10% Shareholder

ACHV

ACHIEVE LIFE SCIENCES, INC. Healthcare

> 10% Shareholder

AMAG

AMAG PHARMACEUTICALS, INC.

> 10% Shareholder

RSLS

ReShape Weightloss Inc.

> 10% Shareholder

INNV

INNOVUS PHARMACEUTICALS, INC.

> 10% Shareholder

ONTX

Onconova Therapeutics, Inc. Healthcare

> 10% Shareholder

VXRT

Vaxart, Inc. Healthcare

Director

TTPH

TETRAPHASE PHARMACEUTICALS INC

Director

TENX

TENAX THERAPEUTICS, INC. Healthcare

Director

CYTH

Cyclo Therapeutics, Inc. Healthcare

> 10% Shareholder

RSLS

ReShape Lifesciences Inc. Healthcare

> 10% Shareholder

ACL